Literature DB >> 19289514

A comprehensive survey of single nucleotide polymorphisms (SNPs) across Mycobacterium bovis strains and M. bovis BCG vaccine strains refines the genealogy and defines a minimal set of SNPs that separate virulent M. bovis strains and M. bovis BCG strains.

M Carmen Garcia Pelayo1, Swapna Uplekar, Andrew Keniry, Pablo Mendoza Lopez, Thierry Garnier, Javier Nunez Garcia, Laura Boschiroli, Xiangmei Zhou, Julian Parkhill, Noel Smith, R Glyn Hewinson, Stewart T Cole, Stephen V Gordon.   

Abstract

To further unravel the mechanisms responsible for attenuation of the tuberculosis vaccine Mycobacterium bovis BCG, comparative genomics was used to identify single nucleotide polymorphisms (SNPs) that differed between sequenced strains of Mycobacterium bovis and M. bovis BCG. SNPs were assayed in M. bovis isolates from France and the United Kingdom and from different BCG vaccines in order to identify those that arose during the attenuation process which gave rise to BCG. Informative data sets were obtained for 658 SNPs from 21 virulent M. bovis strains and 13 BCG strains; these SNPs showed phylogenetic clustering that was consistent with the geographical origin of the strains and previous schemes for BCG genealogies. The data revealed a closer relationship between BCG Tice and BCG Pasteur than was previously appreciated, while we were able to position BCG Beijing within a grouping of BCG Denmark-derived strains. Only 186 SNPs were identified between virulent M. bovis strains and all BCG strains, with 115 nonsynonymous SNPs affecting important functions such as global regulators, transcriptional factors, and central metabolism, which might impact on virulence. We therefore refine previous genealogies of BCG vaccines and define a minimal set of SNPs between virulent M. bovis strains and the attenuated BCG strain that will underpin future functional analyses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19289514      PMCID: PMC2681724          DOI: 10.1128/IAI.01099-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  58 in total

1.  The N-terminal input domain of the sensor kinase KdpD of Escherichia coli stabilizes the interaction between the cognate response regulator KdpE and the corresponding DNA-binding site.

Authors:  Ralf Heermann; Karlheinz Altendorf; Kirsten Jung
Journal:  J Biol Chem       Date:  2003-10-08       Impact factor: 5.157

2.  The in vitro evolution of BCG vaccines.

Authors:  Serge Mostowy; Anthony G Tsolaki; Peter M Small; Marcel A Behr
Journal:  Vaccine       Date:  2003-10-01       Impact factor: 3.641

3.  The effect of bacille Calmette-Guérin vaccine strain and route of administration on induced immune responses in vaccinated infants.

Authors:  Virginia Davids; Willem A Hanekom; Nazma Mansoor; Hoyam Gamieldien; Sebastian J Gelderbloem; Anthony Hawkridge; Gregory D Hussey; E Jane Hughes; Jorge Soler; Rose Ann Murray; Stanley R Ress; Gilla Kaplan
Journal:  J Infect Dis       Date:  2006-01-13       Impact factor: 5.226

4.  Has BCG attenuated to impotence?

Authors:  M A Behr; P M Small
Journal:  Nature       Date:  1997-09-11       Impact factor: 49.962

5.  A point mutation in the mma3 gene is responsible for impaired methoxymycolic acid production in Mycobacterium bovis BCG strains obtained after 1927.

Authors:  M A Behr; B G Schroeder; J N Brinkman; R A Slayden; C E Barry
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

6.  The Phn system of Mycobacterium smegmatis: a second high-affinity ABC-transporter for phosphate.

Authors:  Susanne Gebhard; Sieu L Tran; Gregory M Cook
Journal:  Microbiology       Date:  2006-11       Impact factor: 2.777

7.  Genetic requirements for mycobacterial survival during infection.

Authors:  Christopher M Sassetti; Eric J Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

8.  The Mycobacterium bovis BCG cyclic AMP receptor-like protein is a functional DNA binding protein in vitro and in vivo, but its activity differs from that of its M. tuberculosis ortholog, Rv3676.

Authors:  Guangchun Bai; Michaela A Gazdik; Damen D Schaak; Kathleen A McDonough
Journal:  Infect Immun       Date:  2007-09-04       Impact factor: 3.441

9.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

10.  The OtsAB pathway is essential for trehalose biosynthesis in Mycobacterium tuberculosis.

Authors:  Helen N Murphy; Graham R Stewart; Vladimir V Mischenko; Alexander S Apt; Richard Harris; Mark S B McAlister; Paul C Driscoll; Douglas B Young; Brian D Robertson
Journal:  J Biol Chem       Date:  2005-02-09       Impact factor: 5.157

View more
  34 in total

1.  BCG sub-strains induce variable protection against virulent pulmonary Mycobacterium tuberculosis infection, with the capacity to drive Th2 immunity.

Authors:  Andrew Keyser; Jolynn M Troudt; Jennifer L Taylor; Angelo A Izzo
Journal:  Vaccine       Date:  2011-10-18       Impact factor: 3.641

2.  New assessment of bovine tuberculosis risk factors in Belgium based on nationwide molecular epidemiology.

Authors:  M-F Humblet; M Gilbert; M Govaerts; M Fauville-Dufaux; K Walravens; C Saegerman
Journal:  J Clin Microbiol       Date:  2010-06-23       Impact factor: 5.948

3.  The BCG Strain Pool: Diversity Matters.

Authors:  Daria Bottai; Roland Brosch
Journal:  Mol Ther       Date:  2016-02       Impact factor: 11.454

4.  A DNA vaccine expressing CFP21 and MPT64 fusion protein enhances BCG-induced protective immunity against Mycobacterium tuberculosis infection in mice.

Authors:  Chun Wang; Zhenhua Chen; Ruiling Fu; Ying Zhang; Lingxia Chen; Li Huang; Jinjin Li; Chunwei Shi; Xionglin Fan
Journal:  Med Microbiol Immunol       Date:  2011-02-22       Impact factor: 3.402

5.  Single nucleotide polymorphisms in the Mycobacterium bovis genome resolve phylogenetic relationships.

Authors:  Deepti Joshi; N Beth Harris; Ray Waters; Tyler Thacker; Barun Mathema; Barry Krieswirth; Srinand Sreevatsan
Journal:  J Clin Microbiol       Date:  2012-09-19       Impact factor: 5.948

Review 6.  Horizontal gene transfers with or without cell fusions in all categories of the living matter.

Authors:  Joseph G Sinkovics
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

7.  Fourteen-genome comparison identifies DNA markers for severe-disease-associated strains of Clostridium difficile.

Authors:  Vincenzo Forgetta; Matthew T Oughton; Pascale Marquis; Ivan Brukner; Ruth Blanchette; Kevin Haub; Vince Magrini; Elaine R Mardis; Dale N Gerding; Vivian G Loo; Mark A Miller; Michael R Mulvey; Maja Rupnik; Andre Dascal; Ken Dewar
Journal:  J Clin Microbiol       Date:  2011-04-20       Impact factor: 5.948

Review 8.  Recombinant BCG as a vaccine vehicle to protect against tuberculosis.

Authors:  James A Triccas
Journal:  Bioeng Bugs       Date:  2009-11-02

9.  Impact of in vitro evolution on antigenic diversity of Mycobacterium bovis bacillus Calmette-Guerin (BCG).

Authors:  Richard Copin; Mireia Coscollá; Sebastien Gagneux; Joel D Ernst; Efstratios Efstathiadis
Journal:  Vaccine       Date:  2014-09-06       Impact factor: 3.641

10.  MSMSpdbb: providing protein databases of closely related organisms to improve proteomic characterization of prokaryotic microbes.

Authors:  Gustavo A de Souza; Magnus Ø Arntzen; Harald G Wiker
Journal:  Bioinformatics       Date:  2010-01-14       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.